Clinical Breakpoints for antifungal agents

EUCAST is the European Committee on Antimicrobial Susceptibility Testing, convened by the ESCMID (The European Society for Clinical Microbiology and Infectious Diseases) and national breakpoint committees in Europe (currently from France, Germany, Netherlands, Norway, Sweden and the UK). EUCAST has representatives from all European countries. EUCAST is financed by ESCMID, national breakpoint committees in Europe and a grant from the European Union.

EUCAST defines clincial breakpoints and epidemiological cut-off values. The clinical breakpoints should be used in everyday clinical laboratory work to advice on therapy in the patient. The epidemiological cut-off values can be used as the most sensitive measure of resistance development - for measuring resistance development in hospitals and the community, for measuring the effect of interventions and for developing strategies to counteract further resistance development. Wild type distributions of relevant bacteria can be acquired from the MIC breakpoint tables by clicking on the name of the antibiotic.  .